David A Fellows - Net Worth and Insider Trading

David A Fellows Net Worth

The estimated net worth of David A Fellows is at least $20 Million dollars as of 2024-09-20. David A Fellows is the CEO of Nightstar Therapeutics PLC and owns about 617,090 shares of Nightstar Therapeutics PLC (NITE) stock worth over $16 Million. David A Fellows is also the CVP, Pres., EuroAsia/Africa/ME of Allergan PLC and owns about 21,131 shares of Allergan PLC (AGN) stock worth over $4 Million. Details can be seen in David A Fellows's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Fellows has not made any transactions after 2019-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of David A Fellows

To

David A Fellows Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David A Fellows owns 1 companies in total, including Terns Pharmaceuticals Inc (TERN) .

Click here to see the complete history of David A Fellows’s form 4 insider trades.

Insider Ownership Summary of David A Fellows

Ticker Comapny Transaction Date Type of Owner
TERN Terns Pharmaceuticals Inc 2021-09-28 director

David A Fellows Latest Holdings Summary

David A Fellows currently owns a total of 2 stocks. Among these stocks, David A Fellows owns 617,090 shares of Nightstar Therapeutics PLC (NITE) as of April 1, 2019, with a value of $16 Million and a weighting of 79.36%. David A Fellows also owns 21,131 shares of Allergan PLC (AGN) as of October 30, 2003, with a value of $4 Million and a weighting of 20.64%.

Latest Holdings of David A Fellows

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NITE Nightstar Therapeutics PLC 2019-04-01 617,090 25.41 15,680,257
AGN Allergan PLC 2003-10-30 21,131 193.02 4,078,706

Holding Weightings of David A Fellows


David A Fellows Form 4 Trading Tracker

According to the SEC Form 4 filings, David A Fellows has made a total of 0 transactions in Nightstar Therapeutics PLC (NITE) over the past 5 years. The most-recent trade in Nightstar Therapeutics PLC is the sale of 9,305 shares on April 1, 2019, which brought David A Fellows around $235,510.

According to the SEC Form 4 filings, David A Fellows has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 21,520 shares on October 30, 2003, which brought David A Fellows around $2 Million.

Insider Trading History of David A Fellows

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David A Fellows Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David A Fellows Ownership Network

Ownership Network List of David A Fellows

No Data

Ownership Network Relation of David A Fellows

Insider Network Chart

David A Fellows Owned Company Details

What does Terns Pharmaceuticals Inc do?

Who are the key executives at Terns Pharmaceuticals Inc?

David A Fellows is the director of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include Chief Financial Officer Mark J. Vignola , director & 10 percent owner Carl L Gordon , and director & 10 percent owner Orbimed Advisors Llc .

Terns Pharmaceuticals Inc (TERN) Insider Trades Summary

Over the past 18 months, David A Fellows made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 5,531 shares made by Mark J. Vignola , a net sale of 47,000 shares made by Jill M. Quigley , and a net purchase of 15,531 shares made by Seokho Bryan Yoon .

In summary, during the past 3 months, insiders sold 169,328 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 476,190 shares, with a net purchase of 306,862 shares. During the past 18 months, 589,991 shares of Terns Pharmaceuticals Inc (TERN) were sold and 509,363 shares were bought by its insiders, resulting in a net sale of 80,628 shares.

Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Terns Pharmaceuticals Inc Insider Transactions

No Available Data

David A Fellows Mailing Address

Above is the net worth, insider trading, and ownership report for David A Fellows. You might contact David A Fellows via mailing address: 2525 Dupont Drive, Irvine Ca 92612.

Discussions on David A Fellows

No discussions yet.